Exact Mass: 394.028219
Exact Mass Matches: 394.028219
Found 133 metabolites which its exact mass value is equals to given mass value 394.028219
,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
Diflufenican
CONFIDENCE standard compound; INTERNAL_ID 594; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 5369; ORIGINAL_PRECURSOR_SCAN_NO 5368 CONFIDENCE standard compound; INTERNAL_ID 594; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 5367; ORIGINAL_PRECURSOR_SCAN_NO 5365 CONFIDENCE standard compound; INTERNAL_ID 594; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 5374; ORIGINAL_PRECURSOR_SCAN_NO 5371 CONFIDENCE standard compound; INTERNAL_ID 594; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 5368; ORIGINAL_PRECURSOR_SCAN_NO 5365 CONFIDENCE standard compound; INTERNAL_ID 594; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 5376; ORIGINAL_PRECURSOR_SCAN_NO 5375 CONFIDENCE standard compound; INTERNAL_ID 594; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 5337; ORIGINAL_PRECURSOR_SCAN_NO 5333 CONFIDENCE standard compound; INTERNAL_ID 4010 CONFIDENCE standard compound; INTERNAL_ID 2315 CONFIDENCE standard compound; INTERNAL_ID 8384
JNJ-7706621
C15H12F2N6O3S (394.06596260000003)
Isorhamnetin 3-sulfate
C16H10O10S (393.99946800000004)
Alilusem
C17H15ClN2O5S (394.03901700000006)
Demethyltorosaflavone C
Kaempferol 7,4-dimethyl ether 3-O-sulfate
C17H14O9S (394.03585140000007)
(2RS,4RS,7SR,9aSR)-7-bromo-2-(bromomethyl)decahydro-6,6,9a-trimethyl-3-methylidene-1-benzoxepin-4-ol|4-hydroxypalisadin C
C15H24Br2O2 (394.01429239999993)
1-[(E)-but-2-en-2-yl]-2,8-dichloro-3,9-dihydroxy-4,7-dimethylbenzo[b]-[1,4]-benzodioxepin-6-one|2,7-Dichlor-3,8-dihydroxy-1,9-dimethyl-6-(1-methyl-propenyl)-dibenzo[b,e][1,4]dioxepin-11-on|2,7-dichloro-3,8-dihydroxy-1,9-dimethyl-6-(1-methyl-propenyl)-dibenzo[b,e][1,4]dioxepin-11-one|aspergillusidone C
methyl salicylate beta-D-glucopyranosyl-4-sulphate|sulfatricalysine A
Daphnoretine Acetate
relative retention time with respect to 9-anthracene Carboxylic Acid is 1.101 relative retention time with respect to 9-anthracene Carboxylic Acid is 1.102
1-[(Z)-but-2-en-2-yl]-2,8-dichloro-3,9-dihydroxy-4,7-dimethylbenzo[b][1,4]benzodioxepin-6-one
7-O-acetyldaphnoretin
Origin: Plant, Coumarins
1h,1h,2h,3h,3h-perfluorononane-1,2-diol
C9H7F13O2 (394.02384379999995)
2-(4-DIMETHYLAMINOSTYRYL)-3-METHYLBENZOTHIAZOLIUM PERCHLORATE
C18H19ClN2O4S (394.07540040000004)
phenyl 1,4-diamino-9,10-dihydro-9,10-dioxoanthracene-2-sulphonate
C20H14N2O5S (394.06233940000004)
2-(4-methoxyphenyl)-3-(2-methyl-5-nitrophenyl)sulfonyl-1,3-thiazolidine
Gonyautoxin II
From Gonyaulax and Protogonyaulax subspecies Gonyautoxin II is found in mollusks.
2-(2-Methoxyphenyl)-3-[(2-methyl-5-nitrophenyl)sulfonyl]-1,3-thia zolidine
3,3-Diaminobenzidine tetra hydrochloride 2-hydrate
1,5,5-trimethyl-3-(4-methylphenyl)sulfonyl-4H-imidazol-1-ium,iodide
1-Ethyl-1-methylpyrrolidinium bis(trifluoromethylsulfonyl)imide
2-BUTYNYLTRIPHENYLPHOSPHONIUM BROMIDE
C22H20BrP (394.04859100000004)
1-(3-CHLOROPHENYL)-3-(1-(3,4-DICHLOROBENZYL)-1H-PYRAZOL-3-YL)UREA
5-(4-chlorophenoxy)-3-[3-(trifluoromethyl)phenyl]-1,2,4-triazine-6-carboxamide
Alilusem
C17H15ClN2O5S (394.03901700000006)
C78275 - Agent Affecting Blood or Body Fluid > C448 - Diuretic
4-{[3-chloro-5-(trifluoromethyl)-2-pyridinyl]oxy}-N-isopropylbenzenesulfonamide
2-chloro-N-[3-cyano-4-[(4-methoxyphenyl)thio]phenyl]benzamide
3-chloro-N-[3-cyano-4-[(4-methoxyphenyl)thio]phenyl]benzamide
2-[[1-oxo-2-(1H-1,2,4-triazol-5-ylthio)ethyl]amino]-4-thiophen-2-yl-3-thiophenecarboxylic acid ethyl ester
N-[5-(2-chlorophenyl)-1,3,4-thiadiazol-2-yl]-2-[(4-methyl-1,2,4-triazol-3-yl)thio]butanamide
[(2R)-2-amino-3-(carboxymethylamino)-3-oxopropyl]sulfanyl-methylmercury
(2R,3R,4R,5R,6R)-2-[[(2S,3R,4S,5S)-2,5-bis(chloromethyl)-3,4-dihydroxyoxolan-2-yl]methyl]-5-chloro-6-(hydroxymethyl)oxane-3,4-diol
7-Hydroxy-2-(3-methoxy-4-oxidophenyl)-4-oxo-3-sulfooxychromen-5-olate
C16H10O10S-2 (393.99946800000004)
2-(4-bromophenoxy)-N-[(2-hydroxy-5-methylanilino)-sulfanylidenemethyl]acetamide
C16H15BrN2O3S (393.99867000000006)
2-{4-[(2-Aminophenyl)thio]-3-nitrobenzoyl}benzoic acid
C20H14N2O5S (394.06233940000004)
4-(1,3-dioxo-2-isoindolyl)-N-(4-methyl-2-pyrimidinyl)benzenesulfonamide
C19H14N4O4S (394.07357240000005)
Uracil octosyl acid 5-phosphate
C12H15N2O11P (394.04134500000004)
An N-glycosyl compound with formula C12H15N2O11P that is a common intermediate in the biosynthesis of nikkomycins and polyoxins by bacteria.
(6E)-2-(ethylsulfonyl)-6-(4-hydroxy-3-methoxybenzylidene)-5-imino-5,6-dihydro-7H-[1,3,4]thiadiazolo[3,2-a]pyrimidin-7-one
N-(6-methylsulfonyl-1,3-benzothiazol-2-yl)-4-oxo-4-thiophen-2-ylbutanamide
C16H14N2O4S3 (394.01156840000004)
2-Chloro-5-[[[[(3,5-dimethoxyphenyl)-oxomethyl]amino]-sulfanylidenemethyl]amino]benzoic acid
C17H15ClN2O5S (394.03901700000006)
2-[[5-Cyano-2-(3,4-dimethoxyphenyl)-4-oxo-2,3-dihydro-1,3-thiazin-6-yl]thio]acetic acid ethyl ester
Ethyl 4,5-dimethyl-2-[({[3-(2-thienyl)acryloyl]amino}carbonothioyl)amino]-3-thiophenecarboxylate
ethyl 2-[(2-chlorophenyl)sulfanylmethyl]-5-methyl-4-oxo-3H-thieno[2,3-d]pyrimidine-6-carboxylate
C17H15ClN2O3S2 (394.02125900000004)
5-O-phosphono-2-deoxyribosyl-(3->5)-2,3-dideoxyribose
A 2-deoxyribose bisphosphate that is 2-deoxy-alpha-D-ribofuranose 3,5-bisphosphate in which the phosphate group at position 3 is esterfied by a 2,3-dideoxy-alpha-D-ribofuranos-5-yl group.
2-Bromo-4-chloro-6-[[4-(4-morpholinyl)anilino]methylidene]-1-cyclohexa-2,4-dienone
Ethyl 5-phenyl-1-(2,4,6-trichlorophenyl)pyrazole-4-carboxylate
5-[(2-Bromo-6-chlorophenyl)methyl]-1-tert-butyl-4-pyrazolo[3,4-d]pyrimidinone
4-[(1-Methyl-5-tetrazolyl)thio]-5-[3-(trifluoromethyl)phenyl]thieno[2,3-d]pyrimidine
N2,N9-dimethyl-11-oxo-5,6-dihydrodibenzo[3,1-b:3,1-f][7]annulene-2,9-disulfonamide
4-[(1-Methyl-5-tetrazolyl)thio]-5-[2-(trifluoromethyl)phenyl]thieno[2,3-d]pyrimidine
4-[(1-Methyl-5-tetrazolyl)thio]-5-[4-(trifluoromethyl)phenyl]thieno[2,3-d]pyrimidine
N-[3-(3H-1,3-benzoxazol-2-ylidene)-4-oxo-1-cyclohexa-1,5-dienyl]-2-(4-chlorophenoxy)acetamide
C21H15ClN2O4 (394.07203000000004)
(7Z)-2-Amino-4-(2-chlorophenyl)-7-[(2-chlorophenyl)methylidene]-5,6-dihydro-4H-cyclopenta[b]pyran-3-carbonitrile
C22H16Cl2N2O (394.06396259999997)
(11-Hydroxy-16,18-dioxo-6,8,19-trioxapentacyclo[10.7.0.02,9.03,7.013,17]nonadeca-1(12),2(9),4,10,13(17)-pentaen-14-yl) hydrogen sulate
C16H10O10S (393.99946800000004)
3-(enolpyruvyl)uridine 5-monophosphate
C12H15N2O11P (394.04134500000004)
A uridine 5-phosphate that is UMP in which the hydroxy hydrogen at position 3 has been replaced by an enolpyruvyl group.
ARN19874
C19H14N4O4S (394.07357240000005)
ARN19874 is a selective, reversible uncompetitive N-acylphosphatidylethanolamine phospholipase D (NAPE-PLD) activity inhibitor with an IC50 of ~34 μM[1].
M1002
C15H8F6N2O2S (394.02106599999996)
M1002 is a hypoxia-inducible factor-2 (HIF-2) agonist, and can enhance the expression of HIF-2 target genes. M1002 shows synergy with prolyl-hydroxylase domain (PHD) inhibitors[1].
(2e,4e,7s)-8,8,8-trichloro-7-methyl-n-[(1r)-2-methyl-1-(1,3-thiazol-2-yl)propyl]octa-2,4-dienimidic acid
C16H21Cl3N2OS (394.04401060000004)
{4-[2-(acetyloxy)-5-bromo-4-methylphenyl]-4,5-dimethylcyclopent-1-en-1-yl}methyl acetate
(3r,5r,6r,8s,11s)-11-bromo-6-(bromomethyl)-5,8,12,12-tetramethyl-4,7-dioxatricyclo[6.4.0.0³,⁵]dodecane
C15H24Br2O2 (394.01429239999993)
2-(3-chloro-2,5-dihydroxyphenyl)-5-hydroxy-3,7,8-trimethoxychromen-4-one
2-amino-1-{3,5-dibromo-4-[3-(dimethylamino)propoxy]phenyl}ethanol
C13H20Br2N2O2 (393.98914199999996)
[(4r,5r)-4-[2-(acetyloxy)-5-bromo-4-methylphenyl]-4,5-dimethylcyclopent-1-en-1-yl]methyl acetate
6-methoxy-2-oxo-3-[(2-oxochromen-7-yl)oxy]chromen-7-yl acetate
methyl (2r)-2,4,7-trihydroxy-3-oxo-2',4'-dioxaspiro[indene-1,3'-tricyclo[7.3.1.0⁵,¹³]tridecane]-1'(13'),5',7',9',11'-pentaene-2-carboxylate
(1s,2r,4s,12s,13r)-7-hydroxy-13-methoxy-3,11,21,22-tetraoxaheptacyclo[10.9.1.1¹,⁶.1¹²,¹⁶.0²,⁴.0¹⁰,²⁴.0²⁰,²³]tetracosa-6(24),7,9,16,18,20(23)-hexaene-5,15-dione
2-[3-chloro-2-hydroxy-4-methoxy-6-(methoxycarbonyl)benzoyl]-6-hydroxy-4-methylbenzoic acid
(1r)-2-ethyl-5,7,9-trihydroxy-4,6,11-trioxo-1h-tetracene-1-carboxylic acid
methyl 2,4,7-trihydroxy-3-oxo-2',4'-dioxaspiro[indene-1,3'-tricyclo[7.3.1.0⁵,¹³]tridecane]-1'(13'),5',7',9',11'-pentaene-2-carboxylate
4-[(2e)-but-2-en-2-yl]-5,15-dichloro-6,14-dihydroxy-7,12-dimethyl-2,9-dioxatricyclo[9.4.0.0³,⁸]pentadeca-1(15),3(8),4,6,11,13-hexaen-10-one
[5-hydroxy-7-methoxy-2-(4-methoxyphenyl)-4-oxochromen-3-yl]oxidanesulfonic acid
C17H14O9S (394.03585140000007)
(11r,15s)-5-(3,4-dihydroxyphenyl)-9,13-dihydroxy-12-methyl-4,16-dioxatetracyclo[8.6.0.0³,⁸.0¹¹,¹⁵]hexadeca-1(10),2,5,8,12-pentaene-7,14-dione
1,4-dimethyl 2-hydroxy-2-{5-hydroxy-7-methyl-4-oxo-2h,3h-thieno[2,3-b]chromen-2-yl}butanedioate
C18H18O8S (394.07223480000005)
(13r)-7-hydroxy-13-methoxy-3,11,21,22-tetraoxaheptacyclo[10.9.1.1¹,⁶.1¹²,¹⁶.0²,⁴.0¹⁰,²⁴.0²⁰,²³]tetracosa-6(24),7,9,16,18,20(23)-hexaene-5,15-dione
[(2r,7s,9as)-7-bromo-2-(bromomethyl)-6,6,9a-trimethyl-2,5,5a,7,8,9-hexahydro-1-benzoxepin-3-yl]methanol
C15H24Br2O2 (394.01429239999993)
[(2r,5as,7s,9as)-7-bromo-2-(bromomethyl)-6,6,9a-trimethyl-2,5,5a,7,8,9-hexahydro-1-benzoxepin-3-yl]methanol
C15H24Br2O2 (394.01429239999993)
(2e,4e)-8,8,8-trichloro-7-methyl-n-[2-methyl-1-(1,3-thiazol-2-yl)propyl]octa-2,4-dienimidic acid
C16H21Cl3N2OS (394.04401060000004)
(1r)-2-amino-1-{3,5-dibromo-4-[3-(dimethylamino)propoxy]phenyl}ethanol
C13H20Br2N2O2 (393.98914199999996)
3-({2-[(1-hydroxyethylidene)amino]ethyl}sulfanyl)-7-oxo-6-[1-(sulfooxy)ethyl]-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylic acid
1,4-dimethyl 2-hydroxy-2-[(2s)-5-hydroxy-7-methyl-4-oxo-2h,3h-thieno[2,3-b]chromen-2-yl]butanedioate
C18H18O8S (394.07223480000005)
[4,5-dihydroxy-2-(hydroxymethyl)-6-[2-(methoxycarbonyl)phenoxy]oxan-3-yl]oxidanesulfonic acid
8,8,8-trichloro-7-methyl-n-[2-methyl-1-(1,3-thiazol-2-yl)propyl]octa-2,4-dienimidic acid
C16H21Cl3N2OS (394.04401060000004)
(5r,6r)-3-({2-[(1-hydroxyethylidene)amino]ethyl}sulfanyl)-7-oxo-6-[(1s)-1-(sulfooxy)ethyl]-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylic acid
[(2r,3s,4r,5r,6s)-4,5-dihydroxy-2-(hydroxymethyl)-6-[2-(methoxycarbonyl)phenoxy]oxan-3-yl]oxidanesulfonic acid
1,4-dimethyl (2s)-2-hydroxy-2-[(2s)-5-hydroxy-7-methyl-4-oxo-2h,3h-thieno[2,3-b]chromen-2-yl]butanedioate
C18H18O8S (394.07223480000005)
(2r,4r,7s,9as)-7-bromo-2-(bromomethyl)-6,6,9a-trimethyl-3-methylidene-hexahydro-2h-1-benzoxepin-4-ol
C15H24Br2O2 (394.01429239999993)